14 insiders reported 23 Form 4 transactions for Senti Biosciences, Inc. (SNTI) over the past 18 months (most recent 2026-03-11). Recent activity: Lu Timothy K (CEO) Sell 80,666 shares, Rajangam Kanya (Pres. & Chief Med. & Dev. Off.) Sell 10,757 shares, Lu Timothy K (CEO) Sell 4,191 shares, Rajangam Kanya (Pres. & Chief Med. & Dev. Off.) Sell 1,384 shares, Celadon Partners SPV 24 (Insider) Buy 9.8M shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-11 | Lu Timothy K | CEO | Sell | 80,666 | $0 |
| 2026-03-11 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | Sell | 10,757 | $0 |
| 2026-02-03 | Lu Timothy K | CEO | Sell | 4,191 | $0 |
| 2026-02-03 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | Sell | 1,384 | $0 |
| 2025-03-14 | Celadon Partners SPV 24 | Insider | Buy | 9.8M | $0 |
| 2025-03-12 | SANDELL SCOTT D | Insider | Buy | 3.3M | $0 |
| 2025-03-12 | BASKETT FOREST | Insider | Buy | 3.3M | $0 |
| 2025-03-12 | Florence Anthony A. Jr. | Insider | Buy | 3.3M | $0 |
| 2025-03-12 | New Enterprise Associates 15, L.P. | Insider | Buy | 3.3M | $0 |
| 2025-03-12 | Makhzoumi Mohamad | Insider | Buy | 3.3M | $0 |
| 2025-03-12 | NEA Partners 15, L.P. | Insider | Buy | 3.3M | $0 |
| 2025-03-12 | NEA 15 GP, LLC | Insider | Buy | 3.3M | $0 |
| 2025-03-12 | BAYER AKTIENGESELLSCHAFT | Insider | Buy | 2.2M | $0 |
| 2025-03-12 | BAYER HEALTHCARE LLC | Insider | Buy | 2.2M | $0 |
| 2025-03-12 | Bayer World Investments B.V. | Insider | Buy | 2.2M | $0 |
| 2025-03-12 | Bayer US Holding LP | Insider | Buy | 2.2M | $0 |
| 2025-03-11 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | Buy | 33,000 | $74,250 |
| 2025-03-10 | Lu Timothy K | CEO and Interim PFO and PAO | Buy | 642,358 | $0 |
| 2025-03-10 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | Buy | 78,363 | $0 |
| 2025-02-06 | Lu Timothy K | CEO | Sell | 3,922 | $15,963 |
| 2025-02-06 | Lu Timothy K | CEO | Sell | 545 | $2,376 |
| 2025-02-06 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | Sell | 1,297 | $5,279 |
| 2025-02-06 | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | Sell | 182 | $795 |
Source: SEC Form 4 filings · as of 2026-03-11